Alphatec ATEC
Alphatec Holdings, Inc. · Nasdaq · Surgical & Medical Instruments & Apparatus
$7.04-38.08%close on Oct. 30, 2026 · volume 26.7M · Yahoo Finance
Price, last 49 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Sept. 10, 2026 | Patrick Miles CEO, director | Bought | 115,000 | $8.81 | $1.01 million |
| Aug. 5, 2026 | Tyson Eliot Marshall GENERAL COUNSEL & CORP. SEC. | Sold 10b5-1 plan | 8,168 | $9.65 | $78,821 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 7 →Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedAlphatec Holdings Q3 2026 revenue of $221.2 million misses $225.1 million consensus and cuts full-year revenue outlook to $862 million versus $882.1 million consensus; non-GAAP EPS of $0.09 in line
Results of operations and financial condition · Financial statements and exhibits